Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program
Decheng Ren,1,*
Ho-Chou Tu,1,*
Hyungjin Kim,1
Gary X. Wang,1
Gregory R. Bean,1
Osamu Takeuchi,2
John R. Jeffers,3
Gerard P. Zambetti,3
James J.-D. Hsieh,1
Emily H.-Y. Cheng1,4,,
Abstract:
Although the proteins BAX and BAK are required for initiationof apoptosis at the mitochondria, how BAX and BAK are activatedremains unsettled. We provide in vivo evidence demonstratingan essential role of the proteins BID, BIM, and PUMA in activatingBAX and BAK. Bid, Bim, and Puma triple-knockout mice showedthe same developmental defects that are associated with deficiencyof Bax and Bak, including persistent interdigital webs and imperforatevaginas. Genetic deletion of Bid, Bim, and Puma prevented thehomo-oligomerization of BAX and BAK, and thereby cytochromec–mediated activation of caspases in response to diversedeath signals in neurons and T lymphocytes, despite the presenceof other BH3-only molecules. Thus, many forms of apoptosis requiredirect activation of BAX and BAK at the mitochondria by a memberof the BID, BIM, or PUMA family of proteins.
1 Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. 2 Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan. 3 St. Jude Childrens Research Hospital, Memphis, TN 38105, USA. 4 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
* These authors contributed equally to this work.
Present address: Human Oncology and Pathogenesis Program, MemorialSloan-Kettering Cancer Center, New York, NY 10065, USA.
To whom correspondence should be addressed. E-mail: chenge1{at}mskcc.org
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Seamus J. Martin (3 December 2010) Science330 (6009), 1330.
[DOI: 10.1126/science.1199461] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (7 December 2010) Sci. Signal.3 (151), ec374.
[DOI: 10.1126/scisignal.3151ec374] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Tumor suppressors: enhancers or suppressors of regeneration?.
Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation.
S. Din, M. Mason, M. Volkers, B. Johnson, C. T. Cottage, Z. Wang, A. Y. Joyo, P. Quijada, P. Erhardt, N. S. Magnuson, et al. (2013)
PNAS
110, 5969-5974
|Abstract »|Full Text »|PDF »
PUMA and BIM Are Required for Oncogene Inactivation-Induced Apoptosis.
G. R. Bean, Y. T. Ganesan, Y. Dong, S. Takeda, H. Liu, P. M. Chan, Y. Huang, L. A. Chodosh, G. P. Zambetti, J. J.- D. Hsieh, et al. (2013)
Science Signaling
6, ra20
|Abstract »|Full Text »|PDF »
Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation.
L. Vela, O. Gonzalo, J. Naval, and I. Marzo (2013)
J. Biol. Chem.
288, 4935-4946
|Abstract »|Full Text »|PDF »
Multiple Functions of BCL-2 Family Proteins.
J. M. Hardwick and L. Soane (2013)
Cold Spring Harb Perspect Biol
5, a008722
|Abstract »|Full Text »|PDF »
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma.
J. C. Mertens, C. D. Fingas, J. D. Christensen, R. L. Smoot, S. F. Bronk, N. W. Werneburg, M. P. Gustafson, A. B. Dietz, L. R. Roberts, A. E. Sirica, et al. (2013)
Cancer Res.
73, 897-907
|Abstract »|Full Text »|PDF »
Where Killers Meet--Permeabilization of the Outer Mitochondrial Membrane during Apoptosis.
T. Bender and J.-C. Martinou (2013)
Cold Spring Harb Perspect Biol
5, a011106
|Abstract »|Full Text »|PDF »
S. X. Ren, A. S. L. Cheng, K. F. To, J. H. M. Tong, M. S. Li, J. Shen, C. C. M. Wong, L. Zhang, R. L. Y. Chan, X. J. Wang, et al. (2012)
Cancer Res.
72, 6512-6523
|Abstract »|Full Text »|PDF »
Death Protein 5 and p53-Upregulated Modulator of Apoptosis Mediate the Endoplasmic Reticulum Stress-Mitochondrial Dialog Triggering Lipotoxic Rodent and Human {beta}-Cell Apoptosis.
D. A. Cunha, M. Igoillo-Esteve, E. N. Gurzov, C. M. Germano, N. Naamane, I. Marhfour, M. Fukaya, J.-M. Vanderwinden, C. Gysemans, C. Mathieu, et al. (2012)
Diabetes
61, 2763-2775
|Abstract »|Full Text »|PDF »
Apoptotic and Nonapoptotic Caspase Functions in Animal Development.
Metabolic Stress in Autophagy and Cell Death Pathways.
B. J. Altman and J. C. Rathmell (2012)
Cold Spring Harb Perspect Biol
4, a008763
|Abstract »|Full Text »|PDF »
A p53 Axis Regulates B Cell Receptor-Triggered, Innate Immune System-Driven B Cell Clonal Expansion.
H. Lee, S. Haque, J. Nieto, J. Trott, J. K. Inman, S. McCormick, N. Chiorazzi, and P. K. A. Mongini (2012)
J. Immunol.
188, 6093-6108
|Abstract »|Full Text »|PDF »
Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma.
K. C. Goldsmith, M. Gross, S. Peirce, D. Luyindula, X. Liu, A. Vu, M. Sliozberg, R. Guo, H. Zhao, C. P. Reynolds, et al. (2012)
Cancer Res.
72, 2565-2577
|Abstract »|Full Text »|PDF »
Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function.
M. J. White, S. M. Schoenwaelder, E. C. Josefsson, K. E. Jarman, K. J. Henley, C. James, M. A. Debrincat, S. P. Jackson, D. C. S. Huang, and B. T. Kile (2012)
Blood
119, 4283-4290
|Abstract »|Full Text »|PDF »
A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth.
D. Y. Chen, Y. Lee, B. A. Van Tine, A. C. Searleman, T. D. Westergard, H. Liu, H.-C. Tu, S. Takeda, Y. Dong, D. R. Piwnica-Worms, et al. (2012)
Cancer Res.
72, 736-746
|Abstract »|Full Text »|PDF »
Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.
M. Gupta, A. E. W. Hendrickson, S. S. Yun, J. J. Han, P. A. Schneider, B. D. Koh, M. J. Stenson, L. E. Wellik, J. C. Shing, K. L. Peterson, et al. (2012)
Blood
119, 476-487
|Abstract »|Full Text »|PDF »
Natural Diterpenoid Compound Elevates Expression of Bim Protein, Which Interacts with Antiapoptotic Protein Bcl-2, Converting It to Proapoptotic Bax-like Molecule.
L. Zhao, F. He, H. Liu, Y. Zhu, W. Tian, P. Gao, H. He, W. Yue, X. Lei, B. Ni, et al. (2012)
J. Biol. Chem.
287, 1054-1065
|Abstract »|Full Text »|PDF »
Mechanical stretch induces the apoptosis regulator PUMA in vascular smooth muscle cells.
W.-P. Cheng, B.-W. Wang, S.-C. Chen, H. Chang, and K.-G. Shyu (2012)
Cardiovasc Res
93, 181-189
|Abstract »|Full Text »|PDF »
Mechanisms of ER Stress-Induced Apoptosis in Atherosclerosis.
C. M. Scull and I. Tabas (2011)
Arterioscler Thromb Vasc Biol
31, 2792-2797
|Abstract »|Full Text »|PDF »
Deficiency of Pro-apoptotic Hrk Attenuates Programmed Cell Death in the Developing Murine Nervous System but Does Not Affect Bcl-x Deficiency-Induced Neuron Apoptosis.
A. P. Ghosh, J. D. Cape, B. J. Klocke, and K. A. Roth (2011)
Journal of Histochemistry & Cytochemistry
59, 976-983
|Abstract »|Full Text »|PDF »
Cutting Edge: Regulatory T Cells Do Not Mediate Suppression via Programmed Cell Death Pathways.
A. L. Szymczak-Workman, G. M. Delgoffe, D. R. Green, and D. A. A. Vignali (2011)
J. Immunol.
187, 4416-4420
|Abstract »|Full Text »|PDF »
The Unfolded Protein Response: Integrating Stress Signals Through the Stress Sensor IRE1{alpha}.
C. Hetz, F. Martinon, D. Rodriguez, and L. H. Glimcher (2011)
Physiol Rev
91, 1219-1243
|Abstract »|Full Text »|PDF »
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets.
E. C. Josefsson, C. James, K. J. Henley, M. A. Debrincat, K. L. Rogers, M. R. Dowling, M. J. White, E. A. Kruse, R. M. Lane, S. Ellis, et al. (2011)
J. Exp. Med.
208, 2017-2031
|Abstract »|Full Text »|PDF »
Bcl-2 Family Genetic Profiling Reveals Microenvironment-Specific Determinants of Chemotherapeutic Response.
J. R. Pritchard, L. A. Gilbert, C. E. Meacham, J. L. Ricks, H. Jiang, D. A. Lauffenburger, and M. T. Hemann (2011)
Cancer Res.
71, 5850-5858
|Abstract »|Full Text »|PDF »
Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors.
J. E. Stadanlick, Z. Zhang, S.-Y. Lee, M. Hemann, M. Biery, M. O. Carleton, G. P. Zambetti, S. J. Anderson, T. Oravecz, and D. L. Wiest (2011)
J. Immunol.
187, 664-675
|Abstract »|Full Text »|PDF »
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.
H. Dai, A. Smith, X. W. Meng, P. A. Schneider, Y.-P. Pang, and S. H. Kaufmann (2011)
J. Cell Biol.
194, 39-48
|Abstract »|Full Text »|PDF »
Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells.
A. J. Smith, H. Dai, C. Correia, R. Takahashi, S.-H. Lee, I. Schmitz, and S. H. Kaufmann (2011)
J. Biol. Chem.
286, 17682-17692
|Abstract »|Full Text »|PDF »
The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.
R. Elkholi, K. V. Floros, and J. E. Chipuk (2011)
Genes & Cancer
2, 523-537
|Abstract »|Full Text »|PDF »